These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24647592)

  • 21. Expression of
    Masunaga A; Omatsu M; Kunimura T; Uematsu S; Kamio Y; Kitami A; Miyagi Y; Hiroshima K; Suzuki T
    J Clin Pathol; 2017 Aug; 70(8):690-696. PubMed ID: 28119349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression.
    Kechagioglou P; Papi RM; Provatopoulou X; Kalogera E; Papadimitriou E; Grigoropoulos P; Nonni A; Zografos G; Kyriakidis DA; Gounaris A
    Anticancer Res; 2014 Mar; 34(3):1387-400. PubMed ID: 24596386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
    Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
    Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
    Koscielny S; V Eggeling F; Dahse R
    Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.
    Poursoltan P; Currey N; Pangon L; van Kralingen C; Selinger CI; Mahar A; Cooper WA; Kennedy CW; McCaughan BC; Trent R; Kohonen-Corish MR
    Lung Cancer; 2012 Aug; 77(2):272-6. PubMed ID: 22542170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activin signaling in microsatellite stable colon cancers is disrupted by a combination of genetic and epigenetic mechanisms.
    Jung B; Gomez J; Chau E; Cabral J; Lee JK; Anselm A; Slowik P; Ream-Robinson D; Messer K; Sporn J; Shin SK; Boland CR; Goel A; Carethers JM
    PLoS One; 2009 Dec; 4(12):e8308. PubMed ID: 20011542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of TNFalpha mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation.
    Kloth JN; Gorter A; ter Haar N; Corver WE; Jordanova ES; Kenter GG; Fleuren GJ
    Mol Immunol; 2008 Jan; 45(1):152-9. PubMed ID: 17560652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal carcinomas and PTEN/MMAC1 gene mutations.
    Dicuonzo G; Angeletti S; Garcia-Foncillas J; Brugarolas A; Okrouzhnov Y; Santini D; Tonini G; Lorino G; De Cesaris M; Baldi A
    Clin Cancer Res; 2001 Dec; 7(12):4049-53. PubMed ID: 11751500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases.
    Karoui M; Tresallet C; Julie C; Zimmermann U; Staroz F; Brams A; Muti C; Boulard C; Robreau AM; Puy H; Malafosse R; Penna C; Pruvot FR; Thiery JP; Boileau C; Rougier P; Nordlinger B; Radvanyi F; Franc B; Hofmann-Radvanyi H
    Br J Cancer; 2004 Mar; 90(6):1230-4. PubMed ID: 15026806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
    Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients.
    Bae JJ; Rho JW; Lee TJ; Yun SS; Kim HJ; Choi JH; Jeong D; Jang BC; Lee TY
    Oncol Rep; 2007 Oct; 18(4):1007-13. PubMed ID: 17786367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.
    Pilozzi E; Onelli MR; Ziparo V; Mercantini P; Ruco L
    J Pathol; 2004 Nov; 204(3):289-95. PubMed ID: 15378566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma.
    Lee AS; Seo YC; Chang A; Tohari S; Eu KW; Seow-Choen F; McGee JO
    Br J Cancer; 2000 Sep; 83(6):750-5. PubMed ID: 10952779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
    Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
    Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma.
    Salvesen HB; MacDonald N; Ryan A; Jacobs IJ; Lynch ED; Akslen LA; Das S
    Int J Cancer; 2001 Jan; 91(1):22-6. PubMed ID: 11149415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma.
    Saffroy R; Riou P; Soler G; Azoulay D; Emile JF; Debuire B; Lemoine A
    Eur J Hum Genet; 2002 Apr; 10(4):239-44. PubMed ID: 12032731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
    Kurose K; Zhou XP; Araki T; Eng C
    Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
    Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M
    Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation- status.
    Danielsen SA; Lind GE; Bjørnslett M; Meling GI; Rognum TO; Heim S; Lothe RA
    Hum Mutat; 2008 Nov; 29(11):E252-62. PubMed ID: 18781614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.